Literature DB >> 3344783

Enlargement of the blind spot caused by papilledema.

J J Corbett1, D M Jacobson, R C Mauer, H S Thompson.   

Abstract

Blind spot enlargement in papilledema has been attributed to either mechanical disruption of the integrity of the peripapillary percipient elements by the swollen optic disk or to the Stiles-Crawford effect. We investigated the possibility that blind spot enlargement in papilledema is caused, at least in part, by a refractive scotoma due to peripapillary hyperopia. We reduced the enlarged blind spot in a patient with focal peripapillary hyperopia, without papilledema, to near normal size by using progressively stronger plus lenses. Similarly, with the addition of plus sphere, we reduced the size of the blind spot in five of six patients with papilledema, but in none of our normal subjects.

Entities:  

Mesh:

Year:  1988        PMID: 3344783     DOI: 10.1016/0002-9394(88)90007-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

Review 1.  Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2017-01-31       Impact factor: 4.849

2.  The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Authors:  Michael Wall; Mark J Kupersmith; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Michael P McDermott
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

Review 3.  Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension.

Authors:  Sarah R Ahmad; Heather E Moss
Journal:  Semin Neurol       Date:  2019-12-17       Impact factor: 3.420

4.  Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Michael Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-29       Impact factor: 4.799

5.  Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension.

Authors:  John J Chen; Matthew J Thurtell; Reid A Longmuir; Mona K Garvin; Jui-Kai Wang; Michael Wall; Randy H Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

6.  Acute visual loss in papilloedema: the diagnostic pitfalls.

Authors:  Hon Shing Ong; Clare Fraser; Indran Davagnanam; Gordon T Plant
Journal:  Int Ophthalmol       Date:  2013-06-08       Impact factor: 2.031

7.  Shape analysis of the peripapillary RPE layer in papilledema and ischemic optic neuropathy.

Authors:  Patrick Sibony; Mark J Kupersmith; F James Rohlf
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-10       Impact factor: 4.799

8.  Idiopathic intracranial hypertension.

Authors:  Michael Wall
Journal:  Neurol Clin       Date:  2010-08       Impact factor: 3.806

Review 9.  Pathogenesis and Evaluation of the Effects of Idiopathic Intracranial Hypertension on the Optic Nerves.

Authors:  Nada Elsaid; Omar Ahmed; Tamer Belal; Ahmed Razek; Ahmed Azab
Journal:  Neuroophthalmology       Date:  2020-06-16

Review 10.  Optical coherence tomography shows retinal abnormalities associated with optic nerve disease.

Authors:  Kirstin L Tawse; Thomas R Hedges; Marisa Gobuty; Carlos Mendoza-Santiesteban
Journal:  Br J Ophthalmol       Date:  2014-03-13       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.